Related Experiment Video
Updated: Jun 29, 2025

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
Interaction between type 2 diabetes and past COVID-19 on active tuberculosis
Liz E Calles-Cabanillas1, Genesis P Aguillón-Durán1, Doris Ayala1
1University of Texas Health Science Center at Houston.
Past COVID-19 and type 2 diabetes mellitus (DM) synergistically increase tuberculosis (TB) risk. Screening for latent TB is recommended for individuals with both conditions.
Area of Science:
- Infectious Diseases
- Endocrinology
- Public Health
Background:
- COVID-19 pandemic disrupted tuberculosis (TB) control efforts globally.
- The direct biological impact of COVID-19 on TB incidence requires further investigation.
- This study examines the association between recent COVID-19 infection and new TB episodes, considering type 2 diabetes mellitus (DM) comorbidity.
Approach:
- A cross-sectional study included 112 new active TB patients and 373 controls from June 2020 to November 2021.
- COVID-19 status was determined by self-report or serology.
- Bivariable and multivariable analyses assessed the odds of new TB in relation to past COVID-19 and DM.
Key Points:
- Past COVID-19 was associated with higher odds of new TB, particularly in patients with DM (aOR 2.3).
- Individuals with DM had a 2.7-fold increased odds of TB without prior COVID-19.
- The odds of TB in DM patients increased to 7.9-fold if they had a history of COVID-19.
Conclusions:
- Type 2 diabetes mellitus and past COVID-19 interact synergistically, significantly elevating TB risk.
- Proactive screening for latent TB and prompt prophylactic treatment are crucial for high-risk individuals with both COVID-19 and DM.
More Related Videos
10:04Analysis of 18FDG PET/CT Imaging as a Tool for Studying Mycobacterium tuberculosis Infection and Treatment in Non-human Primates
Published on: September 5, 2017
09:34An Automated Culture System for Use in Preclinical Testing of Host-Directed Therapies for Tuberculosis
Published on: August 16, 2021
Related Concept Videos
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Diabetes Mellitus: Type 2 and Gestational
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...